Disruptive ScienceDriven by Heart Our mission is to develop novel therapeutics, bridging the innovation gap for patients in China and the world. Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program JIXING Announces Leadership Transition LENZ Therapeutics and JIXING Announce an Exclusive Greater China License Agreement; RTW to Invest in LENZ Therapeutics JIXING is a leading biotechnology company committed to bringing innovative science and medicines to underserved patients in China China Biotech A differentiated China-based biotech with a patient-centric approach dedicated to improving outcomes in Cardiovascular and Ophthalmology. Learn more Strong Pipeline A growing pipeline of high-quality, de-risked assets based on clinical results of our partners and with significant market potential in Greater China. Learn more World-class Team A world-class team with strong clinical execution and regulatory experience, led by a CEO with substantial commercial experience in Greater China. Learn more Strategic Partners Founded and backed by RTW Investments, a leading global, full life-cycle healthcare investment firm and a proven company builder. Learn more